Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Commentary: Rigid Chest Wall Reconstruction-Innovation With Functional Improvements.

Lanuti M.

Semin Thorac Cardiovasc Surg. 2019 Jul 29. pii: S1043-0679(19)30205-9. doi: 10.1053/j.semtcvs.2019.07.012. [Epub ahead of print] No abstract available.

PMID:
31369854
2.

Pulmonary Artery Resection During Lung Resection for Malignancy.

Madariaga MLL, Geller A, Lanuti M, Ott H, Allan JS, Donahue DM, Mathisen DJ, Wright CD, Gaissert HA.

Ann Thorac Surg. 2019 Jul 20. pii: S0003-4975(19)31045-8. doi: 10.1016/j.athoracsur.2019.05.079. [Epub ahead of print]

PMID:
31336066
3.

Postintubation Tracheal Stenosis: Management and Results 1993-2017.

Wright CD, Li S, Geller AD, Lanuti M, Gaissert HA, Muniappan A, Ott HC, Mathisen DJ.

Ann Thorac Surg. 2019 Jul 9. pii: S0003-4975(19)31003-3. doi: 10.1016/j.athoracsur.2019.05.050. [Epub ahead of print]

PMID:
31299233
4.

Type I Collagen-targeted Positron Emission Tomography Imaging in Idiopathic Pulmonary Fibrosis: First-in-Human Studies.

Montesi SB, Izquierdo-Garcia D, Désogère P, Abston E, Liang LL, Digumarthy S, Seethamraju R, Lanuti M, Caravan P, Catana C.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):258-261. doi: 10.1164/rccm.201903-0503LE. No abstract available.

PMID:
31161770
5.

Impact of Radial Margin Status After Esophagectomy for Adenocarcinoma.

Tapias L, Tapias LF, Moonsamy P, Lanuti M, Gaissert HA, Wright CD, Muniappan A, Mathisen DJ, Morse CR.

J Gastrointest Surg. 2019 May 29. doi: 10.1007/s11605-019-04258-1. [Epub ahead of print]

PMID:
31144192
6.

Commentary: Cautious optimism for induction immunotherapy in resectable lung cancer.

Lanuti M.

J Thorac Cardiovasc Surg. 2019 Jul;158(1):277-278. doi: 10.1016/j.jtcvs.2019.04.031. Epub 2019 Apr 24. No abstract available.

PMID:
31103202
7.

68Ga-NODAGA-Indole: An Allysine-Reactive Positron Emission Tomography Probe for Molecular Imaging of Pulmonary Fibrogenesis.

Wahsner J, Désogère P, Abston E, Graham-O'Regan KA, Wang J, Rotile NJ, Schirmer MD, Santos Ferreira DD, Sui J, Fuchs BC, Lanuti M, Caravan P.

J Am Chem Soc. 2019 Apr 10;141(14):5593-5596. doi: 10.1021/jacs.8b12342. Epub 2019 Mar 27.

PMID:
30908032
8.

The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction.

Li S, Ghoshal S, Sojoodi M, Arora G, Masia R, Erstad DJ, Ferriera DS, Li Y, Wang G, Lanuti M, Caravan P, Or YS, Jiang LJ, Tanabe KK, Fuchs BC.

FASEB J. 2019 Jun;33(6):7103-7112. doi: 10.1096/fj.201801699R. Epub 2019 Mar 18.

PMID:
30884252
9.

Carinal surgery: A single-institution experience spanning 2 decades.

Costantino CL, Geller AD, Wright CD, Ott HC, Muniappan A, Mathisen DJ, Lanuti M.

J Thorac Cardiovasc Surg. 2019 May;157(5):2073-2083.e1. doi: 10.1016/j.jtcvs.2018.11.130. Epub 2018 Dec 15.

PMID:
30709673
10.

Expert Consensus Document on Pulmonary Metastasectomy.

Handy JR, Bremner RM, Crocenzi TS, Detterbeck FC, Fernando HC, Fidias PM, Firestone S, Johnstone CA, Lanuti M, Litle VR, Kesler KA, Mitchell JD, Pass HI, Ross HJ, Varghese TK.

Ann Thorac Surg. 2019 Feb;107(2):631-649. doi: 10.1016/j.athoracsur.2018.10.028. Epub 2018 Nov 23. No abstract available.

PMID:
30476477
11.

Feasibility of Perioperative Micro-Computed Tomography of Human Lung Cancer Specimens: A Pilot Study.

Troschel FM, Gottumukkala RV, DiCorpo D, Mario J, Ott HC, Wright CD, Muniappan A, Lanuti M, Yang K, Shepard JO, Nardi V, Michaelson JS, Hariri LP, Fintelmann FJ.

Arch Pathol Lab Med. 2019 Mar;143(3):319-325. doi: 10.5858/arpa.2018-0249-OA. Epub 2018 Nov 20.

PMID:
30457896
12.

SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.

Pennell NA, Neal JW, Chaft JE, Azzoli CG, Jänne PA, Govindan R, Evans TL, Costa DB, Wakelee HA, Heist RS, Shapiro MA, Muzikansky A, Murthy S, Lanuti M, Rusch VW, Kris MG, Sequist LV.

J Clin Oncol. 2019 Jan 10;37(2):97-104. doi: 10.1200/JCO.18.00131. Epub 2018 Nov 16. Erratum in: J Clin Oncol. 2019 Mar 1;37(7):612.

13.

Programmed death ligand 1 and CD8+ immune cell infiltrates in resected primary tracheal malignant neoplasms.

Tapias LF, Shih A, Mino-Kenudson M, Muniappan A, Gaissert HA, Lanuti M, Mathisen DJ, Ott HC.

Eur J Cardiothorac Surg. 2019 Apr 1;55(4):691-698. doi: 10.1093/ejcts/ezy370.

PMID:
30418532
14.

Relative Incremental Cost of Postoperative Complications of Esophagectomy.

Geller AD, Zheng H, Gaissert H, Mathisen D, Muniappan A, Wright C, Lanuti M.

Semin Thorac Cardiovasc Surg. 2019 Summer;31(2):290-299. doi: 10.1053/j.semtcvs.2018.10.010. Epub 2018 Nov 2.

PMID:
30391498
15.

Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis.

Li S, Ghoshal S, Sojoodi M, Arora G, Masia R, Erstad DJ, Lanuti M, Hoshida Y, Baumert TF, Tanabe KK, Fuchs BC.

J Gastrointest Surg. 2019 Jan;23(1):101-111. doi: 10.1007/s11605-018-4004-6. Epub 2018 Oct 26.

16.

Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non-Small Cell Lung Cancer.

Nangia V, Siddiqui FM, Caenepeel S, Timonina D, Bilton SJ, Phan N, Gomez-Caraballo M, Archibald HL, Li C, Fraser C, Rigas D, Vajda K, Ferris LA, Lanuti M, Wright CD, Raskin KA, Cahill DP, Shin JH, Keyes C, Sequist LV, Piotrowska Z, Farago AF, Azzoli CG, Gainor JF, Sarosiek KA, Brown SP, Coxon A, Benes CH, Hughes PE, Hata AN.

Cancer Discov. 2018 Dec;8(12):1598-1613. doi: 10.1158/2159-8290.CD-18-0277. Epub 2018 Sep 25.

PMID:
30254092
17.

Surgical Management of Post-Esophagectomy Tracheo-Bronchial-Esophageal Fistula.

Balakrishnan A, Tapias L, Wright CD, Lanuti MX, Gaissert HA, Mathisen DJ, Muniappan A.

Ann Thorac Surg. 2018 Dec;106(6):1640-1646. doi: 10.1016/j.athoracsur.2018.06.076. Epub 2018 Aug 29.

PMID:
30171850
18.

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.

Ettinger DS, Aisner DL, Wood DE, Akerley W, Bauman J, Chang JY, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower M, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Patel SP, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M.

J Natl Compr Canc Netw. 2018 Jul;16(7):807-821. doi: 10.6004/jnccn.2018.0062.

PMID:
30006423
19.

Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy.

Erstad DJ, Sojoodi M, Taylor MS, Ghoshal S, Razavi AA, Graham-O'Regan KA, Bardeesy N, Ferrone CR, Lanuti M, Caravan P, Tanabe KK, Fuchs BC.

Dis Model Mech. 2018 Jul 30;11(7). pii: dmm034793. doi: 10.1242/dmm.034793.

20.

Fluorodeoxyglucose positron emission tomography for detection of tumor recurrence following radiofrequency ablation in retrospective cohort of stage I lung cancer.

Wang Y, Lanuti M, Bernheim A, Shepard JO, Sharma A.

Int J Hyperthermia. 2018;35(1):1-8. doi: 10.1080/02656736.2018.1466369. Epub 2018 May 3.

PMID:
29719997
21.

Carinal resections.

Tapias L, Lanuti M.

Ann Cardiothorac Surg. 2018 Mar;7(2):309-313. doi: 10.21037/acs.2018.01.21. No abstract available.

22.

Cervical exenteration.

Sachdeva UM, Lanuti M.

Ann Cardiothorac Surg. 2018 Mar;7(2):217-226. doi: 10.21037/acs.2018.03.05. Review.

23.

Early-stage (cT2N0) esophageal cancer: Should induction therapy be a standard?

Lanuti M.

J Thorac Cardiovasc Surg. 2018 May;155(5):2231-2232. doi: 10.1016/j.jtcvs.2018.02.029. Epub 2018 Feb 17. No abstract available.

PMID:
29525256
24.

Angiography Before Posterior Mediastinal Tumor Resection: Selection Criteria and Patient Outcomes.

Madariaga ML, Borges LF, Rabinov JD, Chang DC, Lanuti M, Mathisen DJ, Gaissert HA.

Ann Thorac Surg. 2018 Apr;105(4):1000-1007. doi: 10.1016/j.athoracsur.2017.12.028. Epub 2018 Jan 31.

PMID:
29373823
25.

Prediction models for disease events do not always influence clinical practice.

Lanuti M.

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1909. doi: 10.1016/j.jtcvs.2017.12.084. Epub 2017 Dec 28. No abstract available.

PMID:
29366574
26.

Risk stratification for distant recurrence of resected early stage non-small cell lung cancer is under construction.

Lanuti M.

J Thorac Cardiovasc Surg. 2018 Mar;155(3):1225-1226. doi: 10.1016/j.jtcvs.2017.10.063. Epub 2017 Nov 1. No abstract available.

PMID:
29305028
27.

Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer.

Geller AD, Zheng H, Mathisen DJ, Wright CD, Lanuti M.

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1804-1811. doi: 10.1016/j.jtcvs.2017.11.025. Epub 2017 Nov 20.

PMID:
29254638
28.

Reply to Wijmans et al.: Optical Coherence Tomography: A Valuable Novel Tool for Assessing the Alveolar Compartment in Interstitial Lung Disease?

Hariri LP, Adams DC, Wain JC, Lanuti M, Muniappan A, Sharma A, Colby TV, Mino-Kenudson M, Mark EJ, Kradin RL, Goulart H, Suter MJ.

Am J Respir Crit Care Med. 2018 May 1;197(9):1232-1233. doi: 10.1164/rccm.201711-2347LE. No abstract available.

29.

Transatlantic Editorial: thoracic surgeons need recognition of competence in thoracic oncology.

Massard G, Antonoff MB, Noel JL, Brunelli A, Farjah F, Lanuti M, Van Raemdonck D.

Eur J Cardiothorac Surg. 2017 Oct 1;52(4):611-615. doi: 10.1093/ejcts/ezx294. No abstract available.

PMID:
29156024
30.

Transatlantic Editorial: Thoracic Surgeons Need Recognition of Competence in Thoracic Oncology.

Massard G, Antonoff MB, Noel JL, Brunelli A, Farjah F, Lanuti M, Van Raemdonck D.

Ann Thorac Surg. 2017 Oct;104(4):1103-1107. doi: 10.1016/j.athoracsur.2017.04.068. No abstract available.

PMID:
28935295
31.

Endobronchial Optical Coherence Tomography for Low-Risk Microscopic Assessment and Diagnosis of Idiopathic Pulmonary Fibrosis In Vivo.

Hariri LP, Adams DC, Wain JC, Lanuti M, Muniappan A, Sharma A, Colby TV, Mino-Kenudson M, Mark EJ, Kradin RL, Goulart H, Tager AM, Suter MJ.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):949-952. doi: 10.1164/rccm.201707-1446LE. No abstract available.

32.

Transatlantic editorial: Thoracic surgeons need recognition of competence in thoracic oncology.

Massard G, Antonoff MB, Noel JL, Brunelli A, Farjah F, Lanuti M, Van Raemdonck D.

J Thorac Cardiovasc Surg. 2017 Oct;154(4):1387-1392. doi: 10.1016/j.jtcvs.2017.07.019. No abstract available.

PMID:
28918925
33.

Surgical Management of Esophageal Epiphrenic Diverticula: A Transthoracic Approach Over Four Decades.

Tapias LF, Morse CR, Mathisen DJ, Gaissert HA, Wright CD, Allan JS, Lanuti M.

Ann Thorac Surg. 2017 Oct;104(4):1123-1130. doi: 10.1016/j.athoracsur.2017.06.017. Epub 2017 Aug 25. Review.

PMID:
28847539
34.

Sampling of Suspicious Solitary Pulmonary Nodules: Electromagnetic Navigational Bronchoscopy and Video-Assisted Thoracoscopic Surgery.

Madariaga MLL, Lanuti M.

Semin Roentgenol. 2017 Jul;52(3):178-184. doi: 10.1053/j.ro.2017.06.003. Epub 2017 Jun 3. Review. No abstract available.

PMID:
28734401
35.

Optimization of a Collagen-Targeted PET Probe for Molecular Imaging of Pulmonary Fibrosis.

Désogère P, Tapias LF, Rietz TA, Rotile N, Blasi F, Day H, Elliott J, Fuchs BC, Lanuti M, Caravan P.

J Nucl Med. 2017 Dec;58(12):1991-1996. doi: 10.2967/jnumed.117.193532. Epub 2017 Jun 13.

36.

Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis.

Chen HH, Waghorn PA, Wei L, Tapias LF, Schühle DT, Rotile NJ, Jones CM, Looby RJ, Zhao G, Elliott JM, Probst CK, Mino-Kenudson M, Lauwers GY, Tager AM, Tanabe KK, Lanuti M, Fuchs BC, Caravan P.

JCI Insight. 2017 Jun 2;2(11). pii: 91506. doi: 10.1172/jci.insight.91506. eCollection 2017 Jun 2.

37.

Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, D'Amico TA, DeCamp MM, Dilling TJ, Dobelbower M, Doebele RC, Govindan R, Gubens MA, Hennon M, Horn L, Komaki R, Lackner RP, Lanuti M, Leal TA, Leisch LJ, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M.

J Natl Compr Canc Netw. 2017 Apr;15(4):504-535.

PMID:
28404761
38.

Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models.

Désogère P, Tapias LF, Hariri LP, Rotile NJ, Rietz TA, Probst CK, Blasi F, Day H, Mino-Kenudson M, Weinreb P, Violette SM, Fuchs BC, Tager AM, Lanuti M, Caravan P.

Sci Transl Med. 2017 Apr 5;9(384). pii: eaaf4696. doi: 10.1126/scitranslmed.aaf4696.

39.

Surgical Management of Lung Cancer Involving the Chest Wall.

Lanuti M.

Thorac Surg Clin. 2017 May;27(2):195-199. doi: 10.1016/j.thorsurg.2017.01.013. Review.

PMID:
28363374
40.

Successful Treatment of an Aggressive Tracheal Malignancy With Immunotherapy.

Osho AA, Azzoli CJ, Pai S, Mino-Kenudson M, Faquin WC, Huynh TG, Lanuti M, Mathisen DJ, Muniappan A.

Ann Thorac Surg. 2017 Feb;103(2):e123-e125. doi: 10.1016/j.athoracsur.2016.08.021.

PMID:
28109369
41.

Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.

Nakagawa S, Wei L, Song WM, Higashi T, Ghoshal S, Kim RS, Bian CB, Yamada S, Sun X, Venkatesh A, Goossens N, Bain G, Lauwers GY, Koh AP, El-Abtah M, Ahmad NB, Hoshida H, Erstad DJ, Gunasekaran G, Lee Y, Yu ML, Chuang WL, Dai CY, Kobayashi M, Kumada H, Beppu T, Baba H, Mahajan M, Nair VD, Lanuti M, Villanueva A, Sangiovanni A, Iavarone M, Colombo M, Llovet JM, Subramanian A, Tager AM, Friedman SL, Baumert TF, Schwarz ME, Chung RT, Tanabe KK, Zhang B, Fuchs BC, Hoshida Y; Precision Liver Cancer Prevention Consortium.

Cancer Cell. 2016 Dec 12;30(6):879-890. doi: 10.1016/j.ccell.2016.11.004.

42.

Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases.

Uruga H, Bozkurtlar E, Huynh TG, Muzikansky A, Goto Y, Gomez-Caraballo M, Hata AN, Gainor JF, Mark EJ, Engelman JA, Lanuti MD, Mino-Kenudson M.

J Thorac Oncol. 2017 Mar;12(3):458-466. doi: 10.1016/j.jtho.2016.10.015. Epub 2016 Nov 2.

43.

Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment.

Huynh TG, Morales-Oyarvide V, Campo MJ, Gainor JF, Bozkurtlar E, Uruga H, Zhao L, Gomez-Caraballo M, Hata AN, Mark EJ, Lanuti M, Engelman JA, Mino-Kenudson M.

J Thorac Oncol. 2016 Nov;11(11):1869-1878. doi: 10.1016/j.jtho.2016.08.134. Epub 2016 Aug 24.

44.

Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.

Chiurchiù V, Rapino C, Talamonti E, Leuti A, Lanuti M, Gueniche A, Jourdain R, Breton L, Maccarrone M.

J Immunol. 2016 Nov 1;197(9):3545-3553. Epub 2016 Sep 30.

45.

Managing Controversial Issues in Thoracic Surgery.

Lanuti M.

Thorac Surg Clin. 2016 Aug;26(3):ix. doi: 10.1016/j.thorsurg.2016.05.001. No abstract available.

PMID:
27427531
46.

Surgical Management of Oligometastatic Non-Small Cell Lung Cancer.

Lanuti M.

Thorac Surg Clin. 2016 Aug;26(3):287-94. doi: 10.1016/j.thorsurg.2016.04.002. Review.

PMID:
27427523
47.

NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.

Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Dilling T, Dobelbower M, Govindan R, Hennon M, Horn L, Jahan TM, Komaki R, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Sharma N, Swanson SJ, Stevenson J, Tauer K, Yang SC, Gregory K, Hughes M.

J Natl Compr Canc Netw. 2016 Jul;14(7):825-36.

PMID:
27407123
48.

Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.

Catanzaro G, Pucci M, Viscomi MT, Lanuti M, Feole M, Angeletti S, Grasselli G, Mandolesi G, Bari M, Centonze D, D'Addario C, Maccarrone M.

J Neuroimmunol. 2016 May 15;294:32-40. doi: 10.1016/j.jneuroim.2016.03.009. Epub 2016 Mar 19.

PMID:
27138096
49.

Feasibility of a procedure does not always translate to what is most efficacious.

Lanuti M.

J Thorac Cardiovasc Surg. 2016 Jun;151(6):e109. doi: 10.1016/j.jtcvs.2016.03.004. Epub 2016 Mar 8. No abstract available.

50.

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016.

Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower MC, Govindan R, Hennon M, Horn L, Jahan TM, Komaki R, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Sharma N, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M.

J Natl Compr Canc Netw. 2016 Mar;14(3):255-64.

PMID:
26957612

Supplemental Content

Loading ...
Support Center